Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec.

Gilca R, De Wals P, Nolan SM, Kitchin N, Eiden JJ, Jiang Q, Jones CH, Jansen KU, Anderson AS, Pedneault L.

mSphere. 2018 Dec 5;3(6). pii: e00427-18. doi: 10.1128/mSphere.00427-18.

2.

Clostridium difficile: Investigating Transmission Patterns between Infected and Colonized Patients using whole Genome Sequencing.

Kong LY, Eyre DW, Corbeil J, Raymond F, Walker AS, Wilcox MH, Crook DW, Michaud S, Toye B, Frost E, Dendukuri N, Schiller I, Bourgault AM, Dascal A, Oughton M, Longtin Y, Poirier L, Brassard P, Turgeon N, Gilca R, Loo VG.

Clin Infect Dis. 2018 May 28. doi: 10.1093/cid/ciy457. [Epub ahead of print]

PMID:
29846557
3.

Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.

Tsang RSW, Ahmad T, Tyler S, Lefebvre B, Deeks SL, Gilca R, Hoang L, Tyrrell G, Van Caeseele P, Van Domselaar G, Jamieson FB.

Int J Infect Dis. 2018 Apr;69:55-62. doi: 10.1016/j.ijid.2018.01.019. Epub 2018 Feb 4.

4.

Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era.

Anderson G, Deceuninck G, Zhou Z, Boucher FD, Bonnier Viger Y, Gilca R, De Wals P.

Epidemiol Infect. 2017 Oct;145(13):2770-2776. doi: 10.1017/S0950268817001510. Epub 2017 Aug 14.

PMID:
28803551
5.

Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.

De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N.

Clin Infect Dis. 2017 May 1;64(9):1263-1267. doi: 10.1093/cid/cix154.

PMID:
28207068
6.

Effect Of Detecting and Isolating Asymptomatic Clostridium difficile Carriers-Reply.

Longtin Y, Gilca R, Loo VG.

JAMA Intern Med. 2016 Oct 1;176(10):1573. doi: 10.1001/jamainternmed.2016.5342. No abstract available.

PMID:
27695841
7.

Repeat Influenza Vaccination and High-Dose Efficacy.

Skowronski DM, Chambers C, Gilca R, De Serres G.

Clin Infect Dis. 2016 Nov 1;63(9):1265-1266. Epub 2016 Aug 9. No abstract available.

PMID:
27506686
8.

Evaluation of the New World Health Organization Case Definition of Severe Acute Respiratory Infection for Influenza Surveillance During the Peak Weeks of Two Influenza Seasons in Quebec, Canada.

Amini R, Gilca R, Douville-Fradet M, Boulianne N, De Serres G.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):297-300. doi: 10.1093/jpids/piw044.

PMID:
27496537
9.

MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.

Cristea VC, Oprea M, Neacşu G, Gîlcă R, Popa MI, Usein CR.

Roum Arch Microbiol Immunol. 2015 Jul-Dec;74(3-4):73-8.

PMID:
27328520
10.

Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Lévesque S, Ben-David D, Cloutier I, Loo VG.

JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.

PMID:
27111806
11.

Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada.

Zhou Z, Gilca R, Deceuninck G, Boucher FD, Charest H, DE Wals P.

Epidemiol Infect. 2016 Apr;144(5):1035-44. doi: 10.1017/S0950268815002204. Epub 2015 Sep 18.

PMID:
26381086
12.

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Jones CH, Mohamed N, Rojas E, Andrew L, Hoyos J, Hawkins JC, McNeil LK, Jiang Q, Mayer LW, Wang X, Gilca R, De Wals P, Pedneault L, Eiden J, Jansen KU, Anderson AS.

J Clin Microbiol. 2016 Jan;54(1):25-34. doi: 10.1128/JCM.01447-15. Epub 2015 Aug 26.

14.

Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.

Gilca R, Skowronski DM, Douville-Fradet M, Amini R, Boulianne N, Rouleau I, Martineau C, Charest H, De Serres G.

PLoS One. 2015 Jul 22;10(7):e0132195. doi: 10.1371/journal.pone.0132195. eCollection 2015.

15.

Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season.

Gilca R, Amini R, Douville-Fradet M, Charest H, Dubuque J, Boulianne N, Skowronski DM, De Serres G.

Open Forum Infect Dis. 2014 Sep 22;1(2):ofu086. doi: 10.1093/ofid/ofu086. eCollection 2014 Sep.

16.

Predictors of asymptomatic Clostridium difficile colonization on hospital admission.

Kong LY, Dendukuri N, Schiller I, Bourgault AM, Brassard P, Poirier L, Lamothe F, Béliveau C, Michaud S, Turgeon N, Toye B, Frost EH, Gilca R, Dascal A, Loo VG.

Am J Infect Control. 2015 Mar 1;43(3):248-53. doi: 10.1016/j.ajic.2014.11.024.

PMID:
25728150
17.

Letter to the editor.

Tsang RS, Jamieson FB, Lefebvre B, Gilca R.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):8-38. No abstract available.

18.

The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.

Gilca R, Deceuninck G, Lefebvre B, Tsang R, Amini R, Gilca V, Douville-Fradet M, Markowski F, De Wals P.

PLoS One. 2012;7(11):e50659. doi: 10.1371/journal.pone.0050659. Epub 2012 Nov 29.

19.

Identification and proposal of a potentially new clonal complex that is a common cause of MenB disease in Central and Eastern Canada.

Tsang RS, Lefebvre B, Jamieson FB, Gilca R, Deeks SL, Zhou J.

Can J Microbiol. 2012 Oct;58(10):1236-40. doi: 10.1139/w2012-103. Epub 2012 Oct 10.

PMID:
23051561
20.

Attributing cause of death for patients with Clostridium difficile infection.

Gilca R, Frenette C, Thériault N, Fortin É, Villeneuve J.

Emerg Infect Dis. 2012 Oct;18(10):1707-8. doi: 10.3201/eid1810.120202. No abstract available.

21.

School absenteeism as an adjunct surveillance indicator: experience during the second wave of the 2009 H1N1 pandemic in Quebec, Canada.

Kom Mogto CA, De Serres G, Douville Fradet M, Lebel G, Toutant S, Gilca R, Ouakki M, Janjua NZ, Skowronski DM.

PLoS One. 2012;7(3):e34084. doi: 10.1371/journal.pone.0034084. Epub 2012 Mar 30.

22.

Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Zhou J, Lefebvre B, Deng S, Gilca R, Deceuninck G, Law DK, De Wals P, Tsang RS.

J Clin Microbiol. 2012 May;50(5):1545-51. doi: 10.1128/JCM.06835-11. Epub 2012 Feb 15.

23.

Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada.

Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M.

Antimicrob Agents Chemother. 2012 Feb;56(2):639-46. doi: 10.1128/AAC.05411-11. Epub 2011 Nov 21.

24.

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.

Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D.

Vaccine. 2011 Dec 9;30(1):35-41. doi: 10.1016/j.vaccine.2011.10.062. Epub 2011 Nov 7.

PMID:
22063386
25.

Host and pathogen factors for Clostridium difficile infection and colonization.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.

N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.

PMID:
22047560
26.

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM.

Pediatrics. 2011 Nov;128(5):e1084-91. doi: 10.1542/peds.2010-3492. Epub 2011 Oct 10.

PMID:
21987710
27.

Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.

Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M, Fortin É, Dionne M, Boivin G, Skowronski DM.

Influenza Other Respir Viruses. 2011 Jul;5(4):247-55. doi: 10.1111/j.1750-2659.2011.00204.x. Epub 2011 Feb 9.

28.

Tuberculosis may be underestimated in Rwandan women.

Uwizeye CB, De Serres G, Gilca R, Schwartzman K, Gasana M.

Int J Tuberc Lung Dis. 2011 Jun;15(6):776-81. doi: 10.5588/ijtld.10.0454.

PMID:
21575298
29.

Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006.

Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M.

Infect Control Hosp Epidemiol. 2010 Sep;31(9):939-47. doi: 10.1086/655463.

PMID:
20677973
30.

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin ME, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC; Canadian SAVOIR Team.

PLoS Med. 2010 Apr 6;7(4):e1000258. doi: 10.1371/journal.pmed.1000258.

31.

The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization.

Gilca R, De Serres G, Skowronski D, Boivin G, Buckeridge DL.

Am J Epidemiol. 2009 Oct 1;170(7):925-36. doi: 10.1093/aje/kwp195. Epub 2009 Aug 13.

PMID:
19679751
32.

Use administrative databases with caution.

Hubert B, Gilca R.

CMAJ. 2009 Jan 6;180(1):78; author reply 78-9. doi: 10.1503/cmaj.1080124. No abstract available.

33.

Human bocavirus infections in hospitalized children and adults.

Longtin J, Bastien M, Gilca R, Leblanc E, de Serres G, Bergeron MG, Boivin G.

Emerg Infect Dis. 2008 Feb;14(2):217-21. doi: 10.3201/eid1402.070851.

34.

Antibiotic use in children is not influenced by the result of rapid antigen detection test for the respiratory syncytial virus.

Thibeault R, Gilca R, Côté S, De Serres G, Boivin G, Déry P.

J Clin Virol. 2007 Jul;39(3):169-74. Epub 2007 May 25.

PMID:
17532258
35.

Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003.

Canuel M, De Serres G, Duval B, Gilca R, De Wals P, Gilca V.

BMC Infect Dis. 2007 Apr 18;7:31.

36.

Infections by human coronavirus-NL in hospitalized children.

Boivin G, Baz M, Côté S, Gilca R, Deffrasnes C, Leblanc E, Bergeron MG, Déry P, De Serres G.

Pediatr Infect Dis J. 2005 Dec;24(12):1045-8.

PMID:
16371863
37.

Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons.

Gilca R, De Serres G, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, Dery P, Boivin G.

J Infect Dis. 2006 Jan 1;193(1):54-8. Epub 2005 Nov 18.

PMID:
16323132
38.

Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.

Hamelin ME, Côté S, Laforge J, Lampron N, Bourbeau J, Weiss K, Gilca R, DeSerres G, Boivin G.

Clin Infect Dis. 2005 Aug 15;41(4):498-502. Epub 2005 Jul 15.

PMID:
16028158
39.

Human metapneumovirus infections in hospitalized children.

Boivin G, De Serres G, Côté S, Gilca R, Abed Y, Rochette L, Bergeron MG, Déry P.

Emerg Infect Dis. 2003 Jun;9(6):634-40.

Supplemental Content

Support Center